LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015
LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
LATE-BREAKING ABSTRACT: Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014
LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016
LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016
LATE-BREAKING ABSTRACT: Vocal cord dysfunction (VCD) in mild and severe asthma Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014
Effects of beta-blockers on lung function in bronchial asthma patients Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014
Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013
LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014